4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0001193125-26-389890
Chief Commercial Officer acquired 125,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Wiley Matthew T. · Chief Commercial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-14 | Grant or award : show line 1 in the form | +125,000 | 362,133 | D |
Loading xslF345X06/ownership.xml…